Redeye retains its Base Case despite cutting its short-term EBIT forecasts slightly.
Redeye comments on the news that Annexin has announced a rights issue of up to SEK45m.
Nettoomsättningen uppgick till 62,0 MSEK (59,0) i det tredje kvartalet (november-januari) i Purefuns...
Rapportkommentar Q2 Diamyds rapport för det andra kvartalet innehöll inga överraskningar.
Duell publishes its Q2/24 results on Thursday 4th of April.
Redeye updates its estimates for the Q1 2024 report (due 2024-04-25).
Redeye retains its positive view on Hexatronic and keeps its outlook for Hexatronic regarding Q1 and...
Redeye slightly increases its forecasts for Q1, 2024, and 2025 – mostly due to an expected improveme...
The Human Research Ethics Committee (HREC) has provided the green light to commence enrolment for Me...
Redeye takes a positive view of CombinedX’s most recent acquisition Why.
Pricer has updated its financial targets Sales +15% p.
Redeye comments on Embracer’s announced divestment of Gearbox which is acquired by Take-Two for a co...
Den virtuella satellitsnätsoperatören Wyld Networks ("Wyld") har påbörjat leverans av produkter unde...
Redeye provides a short comment on Scandinavian ChemoTech's EUR48k order from a Belgian equine (hors...
In Q4-23, Movinn A/S (“Movinn” or the “Company”) continued to be affected by high vacancy rates, whi...
With the broadening of its Digital Cash technology to support secure Host-based Card Emulation (HCE)...
2024 förväntas bli ett övergångsår men de långsiktiga tillväxtutsikterna framstår som goda.
Redeye comments on Wyld’s Q4 2023 report, which fell short of expectations.
Last week, Cibus issued green notes of EUR 80m and SEK 700m and launched a tender offer for bonds ma...
Redeye comments on the news that Alzecure has announced a rights issue of up to SEK68m in total.
